US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 2.730
  • +0.010+0.37%
Close Apr 26 16:00 ET
  • 2.710
  • -0.020-0.73%
Post 16:05 ET
491.88MMarket Cap-6204P/E (TTM)

About Arbutus Biopharma Company

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Company Profile

SymbolABUS
Company NameArbutus Biopharma
Listing DateJul 20, 2007
Founded2005
CEOMr. Michael J. McElhaugh
MarketNASDAQ
Employees73
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address701 Veterans Circle
CityWarminster
ProvincePennsylvania
CountryUnited States of America
Zip Code18974
Phone1-267-469-0914
Websitehttp://www.arbutusbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael J. McElhaugh
  • Director, Chief Executive Officer and Interim President
  • 1.62M
  • J. Christopher Naftzger
  • General Counsel, Chief Compliance Officer and Secretary
  • --
  • Karen Sims
  • Chief Medical Officer
  • --
  • David C. Hastings
  • Chief Financial Officer and Principal Accounting Officer
  • 1.45M
  • Dr. Michael J. Sofia,PhD
  • Chief Scientific Officer
  • 1.61M
  • Dr. Frank M. Torti, M.D.
  • Chairman of the Board
  • 187.99K
  • Richard C. Henriques, Jr
  • Independent Director
  • 174.24K
  • Keith Manchester, M.D.
  • Independent Director
  • 156.74K
  • Dr. Melissa V. Rewolinski, PhD
  • Independent Director
  • 212.09K
  • Daniel D. Burgess
  • Independent Director
  • 161.74K
  • James R. Meyers
  • Independent Director
  • 176.74K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg